179 related articles for article (PubMed ID: 12084160)
1. Sensitivity of HCV RNA and HIV RNA blood screening assays.
Lelie PN; van Drimmelen HA; Cuypers HT; Best SJ; Stramer SL; Hyland C; Allain JP; Moncharmont P; Defer C; Nübling M; Glauser A; da Silva Cardoso M; Viret JF; Lankinen MH; Grillner L; Wirthmüller U; Coste J; Schottstedt V; Masecar B; Dax EM
Transfusion; 2002 May; 42(5):527-36. PubMed ID: 12084160
[TBL] [Abstract][Full Text] [Related]
2. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
[TBL] [Abstract][Full Text] [Related]
3. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
[TBL] [Abstract][Full Text] [Related]
4. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems.
Beld M; Habibuw MR; Rebers SP; Boom R; Reesink HW
Transfusion; 2000 May; 40(5):575-9. PubMed ID: 10827262
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of automated nucleic acid extraction devices for application in HCV NAT.
Jongerius JM; Bovenhorst M; van der Poel CL; van Hilten JA; Kroes AC; van der Does JA; van Leeuwen EF; Schuurman R
Transfusion; 2000 Jul; 40(7):871-4. PubMed ID: 10924618
[TBL] [Abstract][Full Text] [Related]
9. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
10. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
[TBL] [Abstract][Full Text] [Related]
14. Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.
Vargo J; Smith K; Knott C; Wang S; Fang C; McDonough S; Giachetti C; Caglioti S; Gammon R; Gilbert D; Jackson JB; Richards W; Stramer S; Mimms L
Transfusion; 2002 Jul; 42(7):876-85. PubMed ID: 12375660
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
[TBL] [Abstract][Full Text] [Related]
16. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
Grabarczyk P; van Drimmelen H; Kopacz A; Gdowska J; Liszewski G; Piotrowski D; Górska J; Kuśmierczyk J; Candotti D; Lętowska M; Lelie N; Brojer E
Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
[TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification.
Linnen JM; Gilker JM; Menez A; Vaughn A; Broulik A; Dockter J; Gillotte-Taylor K; Greenbaum K; Kolk DP; Mimms LT; Giachetti C
J Virol Methods; 2002 Apr; 102(1-2):139-55. PubMed ID: 11879702
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
[TBL] [Abstract][Full Text] [Related]
20. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
Ohhashi Y; Pai A; Halait H; Ziermann R
J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
